DOJ cuts deferred prosecution deal with bankrupt pharma
The Department of Justice’s antitrust division has charged Rising Pharmaceuticals with conspiring to fix prices and allocate customers for a generic hypertension drug, but resolved the charge with a deferred prosecution agreement.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10